Home Subjects Licensing

Licensing

MedGenome Inks Licensing Agreement with Natera to Perform Panorama™ Non-Invasive Prenatal Test (NIPT)...

MedGenome will be the first molecular diagnostic lab to establish Non-Invasive Prenatal Testing (NIPT) for chromosomal disease in a facility in India Bangalore, Jan 12, 2015: MEDGENOME, a leader in clinical genomic testing and a provider ofgenomic solutions for personalized...

Kamani Oils receives FDA License

New Delhi, Sep 11, 2015: Kamani Oil Industries Pvt. Ltd.today announced that they have become the first Indian vegetable oil industry to get aFDA drug license for manufacture of Pharmaceutical grade oils and fats (IP/BP/USP/NF) The initiation of the...

Venus Remedies eyes tie-ups for out-licensing drugs

Mumbai, September 25, 2014: Pharma firm Venus Remedies Ltd has targeted a turnover of Rs 1000 crore by FY'18, even as it eyes partners in Europe and the US for out licensing some of its drugs. "We are looking at...

Drug regulator to set up task force to simplify norms

Industry associations seek more time to submit suggestions New Delhi, October 2014 -  The Central Drugs Standard Control Organisation (CDSCO) is looking to change its procedures for various activities, including the process of granting licences. The drug regulator has decided to...

Ranbaxy enters into licensing pact with EPIRUS Switzerland

New Delhi January 10, 2014: Ranbaxy Laboratories on Thursday inked a licensing pact with EPIRUS Switzerland GmbH for BOW015, a biosimilar version of Infliximab prescribed to treat rheumatoid arthritis (RA).EPIRUS Switzerland GmbH is a wholly-owned subsidiary of Boston-based Epirus...

Lupin and Monosol Rx announce licensing agreement for multiple pediatric-focused products

Warren, NJ & Baltimore, MD and Mumbai, October 08, 2016: Lupin Pharmaceutical Inc., the US subsidiary of pharma major Lupin Limited (collectively Lupin) and MonoSol Rx, a specialty pharmaceutical company have entered into a strategic licensing agreement wherein Lupin...

Biocon inks licensing pact with US-based Quark Pharma

New Delhi December 20, 2013: Biotechnology major Biocon today said it has inked a pact with Quark Pharmaceuticals, Inc to develop a range of siRNA (small interfering RNA) based novel therapeutics. The companies have entered into a licensing and collaboration agreement...